Glucose-Based Regulation of miR-451/AMPK Signaling Depends on the OCT1 Transcription Factor

Cell Reports

Volumn 11, Issue 6, 2015, Pages 902-909

  Ansari, Khairul I ^a   Ogawa, Daisuke ^a,b   Rooj, Arun K ^a   Lawler, Sean E ^a   Krichevsky, Anna M ^c   Johnson, Mark D ^a   Chiocca, E Antonio ^a   Bronisz, Agnieszka ^a   Godlewski, Jakub ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KAGAWA UNIVERSITY HOSPITAL   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MICRORNA; MICRORNA 451; OCTAMER TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; MIRN451 MICRORNA, HUMAN; MIRN451 MICRORNA, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME MECHANISM; HUMAN; HUMAN TISSUE; METABOLIC STRESS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; 3T3 CELL LINE; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PROMOTER REGION;

3T3 CELLS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; MICE; MICRORNAS; OCTAMER TRANSCRIPTION FACTOR-1; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84929267929     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.016     Document Type: Article

References (33)

1. Bronisz A., Wang Y., Nowicki M.O., Peruzzi P., Ansari K.I., Ogawa D., Balaj L., De Rienzo G., Mineo M., Nakano I., et al. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 2014, 74:738-750.
2. Cheng C., Li W., Zhang Z., Yoshimura S., Hao Q., Zhang C., Wang Z. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J.Biol. Chem. 2013, 288:13748-13761.
3. Dhruv H.D., McDonough Winslow W.S., Armstrong B., Tuncali S., Eschbacher J., Kislin K., Loftus J.C., Tran N.L., Berens M.E. Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells. PLoS ONE 2013, 8:e72134.
4. Dore L.C., Amigo J.D., Dos Santos C.O., Zhang Z., Gai X., Tobias J.W., Yu D., Klein A.M., Dorman C., Wu W., et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. Natl. Acad. Sci. USA 2008, 105:3333-3338.
5. Farré D., Roset R., Huerta M., Adsuara J.E., Roselló L., Albà M.M., Messeguer X. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003, 31:3651-3653.
6. Flavahan W.A., Wu Q., Hitomi M., Rahim N., Kim Y., Sloan A.E., Weil R.J., Nakano I., Sarkaria J.N., Stringer B.W., et al. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat. Neurosci. 2013, 16:1373-1382.
7. Godlewski J., Bronisz A., Nowicki M.O., Chiocca E.A., Lawler S. microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle 2010, 9:2742-2748.
8. Godlewski J., Newton H.B., Chiocca E.A., Lawler S.E. MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ. 2010, 17:221-228.
9. Godlewski J., Nowicki M.O., Bronisz A., Nuovo G., Palatini J., De Lay M., Van Brocklyn J., Ostrowski M.C., Chiocca E.A., Lawler S.E. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell 2010, 37:620-632.
10. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
11. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energysensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
12. Höring E., Harter P.N., Seznec J., Schittenhelm J., Bühring H.J., Bhattacharyya S., von Hattingen E., Zachskorn C., Mittelbronn M., Naumann U. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress. Acta Neuropathol. 2012, 124:83-97.
13. Iorio M.V., Croce C.M. microRNA involvement in human cancer. Carcinogenesis 2012, 33:1126-1133.
14. Jang T., Calaoagan J.M., Kwon E., Samuelsson S., Recht L., Laderoute K.R. 5'-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat. Int. J. Cancer 2011, 128:2230-2239.
15. Jeon S.M., Hay N. The dark face of AMPK as an essential tumor promoter. Cell. Logist. 2012, 2:197-202.
16. Kang J., Shakya A., Tantin D. Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem. Sci. 2009, 34:491-499.
17. Kang J., Goodman B., Zheng Y., Tantin D. Dynamic regulation of Oct1 during mitosis by phosphorylation and ubiquitination. PLoS ONE 2011, 6:e23872.
18. Li C., Liu V.W., Chiu P.M., Chan D.W., Ngan H.Y. Over-expressions of AMPK subunits in ovarian carcinomas with significant clinical implications. BMC Cancer 2012, 12:357.
19. Liu X., Chhipa R.R., Nakano I., Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol. Cancer Ther. 2014, 13:596-605.
20. Liu X., Chhipa R.R., Pooya S., Wortman M., Yachyshin S., Chow L.M., Kumar A., Zhou X., Sun Y., Quinn B., et al. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc. Natl. Acad. Sci. USA 2014, 111:E435-E444.
21. Lizcano J.M., Göransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Mäkelä T.P., Hardie D.G., Alessi D.R. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23:833-843.
22. Park H.U., Suy S., Danner M., Dailey V., Zhang Y., Li H., Hyduke D.R., Collins B.T., Gagnon G., Kallakury B., et al. AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol. Cancer Ther. 2009, 8:733-741.
23. Rasmussen K.D., O'Carroll D. The miR-144/451eGFP allele, a novel tool for resolving the erythroid potential of hematopoietic precursors. Blood 2011, 118:2988-2992.
24. Ríos M., Foretz M., Viollet B., Prieto A., Fraga M., Costoya J.A., Señarís R. AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors. Cancer Res. 2013, 73:2628-2638.
25. Sanli T., Steinberg G.R., Singh G., Tsakiridis T. AMP-activated protein kinase (AMPK) beyond metabolism: A novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol. Ther. 2013, 15:156-169.
26. Shakya A., Cooksey R., Cox J.E., Wang V., McClain D.A., Tantin D. Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nat. Cell Biol. 2009, 11:320-327.
27. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N.Engl. J. Med. 2005, 352:987-996. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials GroupNational Cancer Institute of Canada Clinical Trials Group.
28. Vartanian A., Singh S.K., Agnihotri S., Jalali S., Burrell K., Aldape K.D., Zadeh G. GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro-oncol. 2014, 16:1167-1175.
29. Wang V.E., Schmidt T., Chen J., Sharp P.A., Tantin D. Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol. Cell. Biol. 2004, 24:1022-1032.
30. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012, 21:297-308.
31. Ward P.S., Thompson C.B. Signaling in control of cell growth and metabolism. Cold Spring Harb. Perspect. Biol. 2012, 4:a006783.
32. Xue Y., Li A., Wang L., Feng H., Yao X. PPSP: prediction of PK-specific phosphorylation site with Bayesian decision theory. BMC Bioinformatics 2006, 7:163.
33. Zeqiraj E., Filippi B.M., Deak M., Alessi D.R., van Aalten D.M. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 2009, 326:1707-1711.